IMIPAT Study - Parathyroid Tissue Injection - Medical University of Vienna
Summary
ClinicalTrials.gov registered a new interventional study (NCT07516990) conducted by the Medical University of Vienna investigating parathyroid tissue injection. The Phase 1 study is listed as actively recruiting and will evaluate safety and preliminary efficacy outcomes in human subjects.
What changed
A new clinical trial registration was added to ClinicalTrials.gov for the IMIPAT Study, an interventional Phase 1 investigation conducted by the Medical University of Vienna evaluating parathyroid tissue injection.
This registration applies to researchers, institutional review boards, and healthcare providers interested in parathyroid research. Results from this study may inform future clinical applications for parathyroid tissue injection procedures.
What to do next
- Monitor for study completion and results posting
- Review outcomes data upon study conclusion
Archived snapshot
Apr 9, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Show glossary
Related changes
Get daily alerts for ClinicalTrials.gov
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NLM.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov publishes new changes.